Department of Bioengineering and Therapeutic Sciences

Wired magazine visits The Kidney Project

Kidney failure is a debilitating and ultimately deadly illness, and a health policy crisis. With 468,000 people on dialysis in the U.S., costing the government $31 billion dollars a year, very little money is spent on researching alternatives to current treatments.

Update from the Dean - September 2017

Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products...

Guo applies curiosity and collaboration to research

“There are lots of important problems. Only attack those for which you can divine simple experiments with clear answers.”—Julius Axelrod

Giacomini to receive North American Scientific Achievement Award

Kathy Giacomini, PhD, a leader in the field of pharmacogenomics, has been named the 2017 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX).

Using antibiotics to stop contamination in cell cultures changes them, study finds

The common lab practice of adding antibiotics to cell cultures to prevent contamination can actually induce genetic changes in the cells, a paper senior-authored by Nadav Ahituv, PhD, found. Ahituv is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department...

Meet D’Anne Duncan

The newest face on campus is D’Anne Duncan, PhD, who just moved here from Nashville, Tennessee.

Meet BTS Alum Adam Mendelsohn

The startup cofounder and CEO shares his company’s goal of developing dermal implants to deliver medicine for diabetes and more.

Meet Ren Dodge, our newest intern

The Department of Bioengineering and Therapeutic Sciences welcomes Ren Dodge as an intern in the Desai Lab.

31st Annual Course on Pharmacokinetics for Pharmaceutical Scientists

A five-day fundamentals course emphasizing basic principles in pharmacokinetics. This is an annual course, now in its 31st year. Presentations will be delivered via lectures and multiple small-group workshops.

NIH training grant supports device innovation at UCSF

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has awarded the UCSF Department of Bioengineering and Therapeutic Sciences (BTS) and the UCSF Department of Surgery a five-year interdisciplinary

Pages